Company profile: Comecer
1.1 - Company Overview
Company description
- Provider of protection technologies in nuclear medicine, isolation, and nuclear power plant equipment, and of screening systems for special applications serving hospitals, universities, industrial groups, and research organizations. Products include aseptic processing and containment systems, a Terbium-161 production line, the IRIS radiopharmaceutical injection system, THERABED protected admission management, ISP radioactive waste management, and dose calibrators.
Products and services
- Aseptic Processing and Containment Systems: Industrial-grade high-tech assemblies that secure aseptic processing and containment for pharmaceutical and nuclear medicine applications, enhancing operator protection and isolation performance in specialized environments
- IRIS: Hospital-grade multi-dose system for radiopharmaceutical injection that improves dosing precision and patient safety during administration, supporting technicians with reliable multi-dose delivery workflows in clinical nuclear medicine
- Terbium-161 Production Line: Custom-engineered production line that fabricates Terbium-161 for radioligand therapy in cancer treatment, enabling specialized radionuclide manufacturing for hospitals and research organizations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Comecer
Dynamic Biosensors
HQ: Germany
Website
- Description: Provider of a platform and analysis system for molecular interaction analysis to identify pharmaceutical substances.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dynamic Biosensors company profile →
Gyros Protein Technologies
HQ: United States
Website
- Description: Provider of peptide synthesizers, reagents, and bioanalysis platforms for universities, biotechnology and pharmaceutical companies, and peptide houses. Offers automated peptide synthesis systems for discovery to pre-clinical studies, Gyrolab systems for high-throughput immunoassays for impurity analysis and titer quantification, PurePep EasyClean kits for catch-and-release peptide purification, and IQ/OQ services for compliant installation and operation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gyros Protein Technologies company profile →
InVitro International
HQ: United States
Website
- Description: Provider of proprietary non-animal testing alternatives, with a pioneering focus on their development and application.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InVitro International company profile →
Champions Oncology
HQ: United States
Website
- Description: Provider of advanced technology solutions and services for personalizing the development and use of oncology drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Champions Oncology company profile →
ChemConnection
HQ: The Netherlands
Website
- Description: Provider of pharmaceutical ingredients and nanomedicines development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ChemConnection company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Comecer
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Comecer
2.2 - Growth funds investing in similar companies to Comecer
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Comecer
4.2 - Public trading comparable groups for Comecer
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →